Improved detection of advanced oxidation protein products in plasma

被引:205
|
作者
Hanasand, Marita [1 ,2 ]
Omdal, Roald [2 ,3 ]
Norheim, Katrine B. [2 ]
Goransson, Lasse G. [2 ,3 ]
Brede, Cato [1 ]
Jonsson, Grete [1 ]
机构
[1] Stavanger Univ Hosp, Dept Med Biochem, N-4068 Stavanger, Norway
[2] Stavanger Univ Hosp, Dept Internal Med, Clin Immunol Unit, N-4068 Stavanger, Norway
[3] Univ Bergen, Inst Internal Med, N-5020 Bergen, Norway
关键词
Advanced oxidation protein products; Protein oxidation; Lipoprotein solubility; Spectrophotometry; Method validation; Chronic inflammation; FREE-RADICALS; STRESS; MYELOPEROXIDASE; ANTIOXIDANTS; BIOMARKERS; MARKER; DAMAGE; ASSAY;
D O I
10.1016/j.cca.2012.01.038
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Oxidative stress has been associated with many diseases and can among others be assessed as increased levels of advanced oxidation protein products (AOPP). Current AOPP methods suffer from poor reproducibility and accuracy due to precipitation of lipids in plasma samples. We therefore aimed to develop a robust method in which plasma lipids are solubilized. Methods: Plasma was diluted with citric acid, and AOPP measured as absorbance at 340 nm. The method was optimized and validated, and then used to analyze AOPP levels in plasma from healthy control subjects (HC), and in three patients groups; chronic kidney disease (CKD), primary Sjogren's Syndrome (pSS) and systemic lupus erythematosus (SLE). Results: AOPP was detected with improved precision compared to established methods where lipids precipitate. Within- and between days variations were less than 1.4% and 22%, respectively. A control chart was established and the long-term reproducibility followed over six months. Conclusions: This improved method detects plasma AOPP with significantly better reproducibility and accuracy compared to previously reported methods. Solubilization of plasma lipids before spectrophotometric measure of AOPP levels is novel. It prevents both loss of lipoproteins due to precipitation and overestimation as a result of light scattering. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:901 / 906
页数:6
相关论文
共 50 条
  • [21] Advanced oxidation protein products in predicting acute kidney injury following cardiac surgery
    Du, Song-lin
    Zeng, Xiang-zhen
    Tian, Jian-wei
    Ai, Jun
    Wan, Jun
    He, Jian-xing
    BIOMARKERS, 2015, 20 (03) : 206 - 211
  • [22] Level of advanced oxidation protein products is associated with subclinical atherosclerosis
    Bagyura, Zsolt
    Takacs, Angela
    Kiss, Loretta
    Dosa, Edit
    Vadas, Reka
    Nguyen, Tin Dat
    Dinya, Elek
    Soos, Pal
    Szelid, Zsolt
    Lang, Orsolya
    Pallinger, Eva
    Kohidai, Laszlo
    Merkely, Bela
    BMC CARDIOVASCULAR DISORDERS, 2022, 22 (01)
  • [23] Advanced glycation end products and advanced oxidation protein products in hemodialyzed patients
    Kalousová, M
    Zima, T
    Tesar, V
    Lachmanová, J
    BLOOD PURIFICATION, 2002, 20 (06) : 531 - 536
  • [24] Plasma advanced oxidation products as an additional tool in assessment of post-infarction heart failure
    Cvetkovic, Tatjana
    Saric, Sandra
    Stefanovic, Nikola
    Stojiljkovic, Vladana
    Djordjevic, Branka
    Stojanovic, Dijana
    Cvetkovic, Mina
    Ilic, Marina Deljanin
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (12)
  • [25] Plasma-Advanced Oxidation Protein Products Are Potent High-Density Lipoprotein Receptor Antagonists In Vivo
    Marsche, Gunther
    Frank, Sasa
    Hrzenjak, Andelko
    Holzer, Michael
    Dirnberger, Sabine
    Wadsack, Christian
    Scharnagl, Hubert
    Stojakovic, Tatjana
    Heinemann, Akos
    Oettl, Karl
    CIRCULATION RESEARCH, 2009, 104 (06) : 750 - 757
  • [26] Plasma level of advanced oxidation protein products as a novel biomarker of acute lung injury following cardiac surgery
    Du, Songlin
    Ai, Jun
    Zeng, Xiangzhen
    Wan, Jun
    Wu, Xu
    He, Jianxing
    SPRINGERPLUS, 2016, 5 : 1 - 7
  • [27] Impact of Residual Renal Function on Plasma Levels of Advanced Oxidation Protein Products and Pentosidine in Peritoneal Dialysis Patients
    Furuya, Ryuichi
    Kumagai, Hiromichi
    Odamaki, Mari
    Takahashi, Masaaki
    Miyaki, Asumi
    Hishida, Akira
    NEPHRON CLINICAL PRACTICE, 2009, 112 (04): : C255 - C261
  • [28] A new oxidative stress marker in patients with nasal polyposis: advanced oxidation protein products (AOPP)
    Veyseller, B.
    Aksoy, P.
    Ertas, B.
    Keskin, M.
    Ozturan, O.
    Yildtirim, Y. S.
    Bayraktar, F. G. I.
    Ozturk, H.
    B-ENT, 2010, 6 (02) : 105 - 109
  • [29] Myeloperoxidase and Advanced Oxidation Protein Products in the Cerebrospinal Fluid in Women and Men with Parkinson's Disease
    Fernandez-Espejo, Emilio
    Rodriguez de Fonseca, Fernando
    Gavito, Ana Luisa
    Cordoba-Fernandez, Antonio
    Chacon, Jose
    Martin de Pablos, Angel
    ANTIOXIDANTS, 2022, 11 (06)
  • [30] Elevated advanced oxidation protein products levels in patients with liver cirrhosis
    Zuwala-Jagiello, Jolanta
    Pazgan-Simon, Monika
    Simon, Krzysztof
    Warwas, Maria
    ACTA BIOCHIMICA POLONICA, 2009, 56 (04) : 679 - 685